Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (3816)	3/19/2001 5:58:45 PM
From: Hank	Respond to of 5582

I second that wager. GUMM is good at only three things 1) selling assets, 2) selling stock, and 3) issuing press release and/or "scientific" studies that are so vague they are inconclusive.

To: Kevin Podsiadlik who wrote (3816)	3/19/2001 6:05:55 PM
From: Mike M	Read Replies (1) \| Respond to of 5582

Hi, Kevin. Did somebody take a dump in your Wheaties? I think the operative issue is SKUs... While I don't know the wording of the acronym, my understanding that every variety of a product has its own SKU(like a UPC code). i.e. cherry flavored Robitussin has one each in both the six and the 10 oz variety....Hence Zicam cold has one and Zicam allergy has another. I don't think anybody is allowed to release the names of other brands from this data but this includes Alka Seltzer, Tylenol, Robitussin, Sudafed etc... It would seem to me that this information has to be taken with a grain of salt in that Zicam cold for instance comes in only one size and flavor so only has one SKU and Robitussin cold syrup may come in 5 or 10 different SKUs... Lets let GUMM feel good about the fact that they have moved up from #20 to #5 despite the fact that the figures are difficult to interpret. Regarding profitability, I think you might be surprised from here forward. The financials suggest that Zicam has been profitable, simply not able to overcome the cost of the gum manufacturing operation... Well that won't be a problem for GUMM any more, will it? I'd even bet your money that Zicam will be profitable this quarter... Hope your investments are doing well.